TORL Targets Hot ADC Space with Oversubscribed $158M Series B-2 4/10/2024

Birth Control Market Evolves as OTC Opill Hits US Stores 4/10/2024

Can $12 Billion Jumpstart Women’s Health? 4/10/2024

Alphabet Soup: AACR and ACC Dominate Headlines This Week 4/10/2024

YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial 4/10/2024

AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit 4/10/2024

7 Billion-Dollar Oncology M&As from Q1 4/10/2024

The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That. 4/10/2024

Poor Customer Data Management Costs Pharma Companies Money: Report 4/10/2024

AACR 2024: What Cancer Researchers Are Talking About 4/10/2024

PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC 7/9/2024

Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study 7/9/2024

House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year 7/9/2024

Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D 7/9/2024

FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication 7/9/2024

US Government Files Appeal in High-Stakes HIV PrEP Patent Battle Against Gilead 7/9/2024

What Does Wegovy’s Launch in China Mean as Biosimilar Competition Emerges? 7/9/2024

Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall 7/9/2024

UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data 7/9/2024

Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs 5/9/2024